Where is Eccogene headquartered?

Eccogene is located in Shanghai, Shanghai.

Who invested in Eccogene?

Eccogene has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Eccogene?

Eccogene closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

eccogene.com

Eccogene

Eccogene discovers and develops translational medicine in metabolic and immune-related diseases.

Business Model:

Revenue: $0

Employees: 1-10

Rankings

Industries / Tags:

Health Care

Detailed Eccogene Information

General Information

Geographic Data

Address:

City: Shanghai

State: Shanghai

Zip:

Country: China

Financial Info

Stage:

series b

Raised Last:

$25M

Raised Total:

$40M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Eccogene is a clinical stage biopharmaceutical company that provides therapeutic solutions to address unmet medical needs. They offer services in the discovery and development of translational medicine in metabolic and immune-related diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
6/2023	Series B		$0	Delos Capital Elikon Venture Huajin Capital New Alliance Capital Oriza Seed Capital (Oriza Yuandian) Qingsong Fund Shanghai Zhangjiang Haocheng Venture Capital Yufu Capital Delos Capital Elikon Venture Huajin Capital New Alliance Capital Oriza Seed Capital (Oriza Yuandian) Qingsong Fund Shanghai Zhangjiang Haocheng Venture Capital Yufu Capital Delos Capital Elikon Venture Huajin Capital New Alliance Capital Oriza Seed Capital (Oriza Yuandian) Qingsong Fund Shanghai Zhangjiang Haocheng Venture Capital Yufu Capital Delos Capital Elikon Venture Huajin Capital New Alliance Capital Oriza Seed Capital (Oriza Yuandian) Qingsong Fund Shanghai Zhangjiang Haocheng Venture Capital Yufu Capital
9/2018	Series A	3	$14.6M	Med-Fine Capital Sinopharm Capital TF Capital Med-Fine Capital Sinopharm Capital TF Capital
6/2023	Series B	8	$25.2M	Delos Capital Elikon Venture Huajin Capital New Alliance Capital Oriza Seed Capital (Oriza Yuandian) Qingsong Fund Shanghai Zhangjiang Haocheng Venture Capital Yufu Capital Delos Capital Elikon Venture Huajin Capital New Alliance Capital Oriza Seed Capital (Oriza Yuandian) Qingsong Fund Shanghai Zhangjiang Haocheng Venture Capital Yufu Capital

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details